[2024年间歇性肺病的更新]
1Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing100730, China.
概括
本综述涵盖了2023-2024年间歇性肺病 (ILD) 中的关键进展,重点关注异常性肺纤维化,结缔组织疾病-ILD和沙尔科伊多सिस.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 类风湿病学 类风湿病学
背景情况:
- 间歇性肺病 (ILD) 涵盖了一组异质的疾病.
- 异常性肺纤维化 (IPF),结缔组织疾病相关的ILD (CTD-ILD) 和沙尔科毒性是具有显著临床影响的主要ILD.
研究的目的:
- 系统地审查ILD病变发生,诊断和治疗方面的显著进展.
- 总结全球和中国的指导方针以及有关关键ILD的专家意见.
- 提供关于该领域科学进展的年度更新.
主要方法:
- 系统审查权威的中国和国际期刊上的出版物.
- 审查时间表:2023年10月至2024年9月.
- 专注于异常性肺纤维化,CTD-ILD和肉类瘤.
主要成果:
- 了解ILDs的病变发生的关键进展.
- 关于ILDs的诊断策略和标准的更新.
- 针对IPF,CTD-ILD和肉类瘤的新治疗方式和治疗指南.
结论:
- 该审查强调了ILD研究和临床实践的重大进展.
- 它为临床医生和研究人员提供了最新发展的全面概述.
- 这种年度更新有助于对患有间歇性肺部疾病的患者进行知情管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-IV: Diagnostic and Management
2.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.4K


